tiprankstipranks
Egetis Therapeutics AB (PDPHF)
FRANKFURT:PDPHF
PDPHF
Egetis Therapeutics AB
RESEARCH TOOLSreports

Egetis Therapeutics AB (PDPHF) Revenue

2 Followers
StatisticsRevenue

Egetis Therapeutics AB Revenue

Egetis Therapeutics AB had a revenue of 17.40M in the quarter ending Jun 30, 2026, with 29.85%. This bring the company's revenue in the last twelve months to 66.10M, Decreased 4.59%. In the fiscal year ending Dec 31, 2025, Egetis Therapeutics AB had annual revenue of 62.40M with 35.36% growth.
Revenue (ttm)
66.10M
Revenue Growth
―
P/S Ratio
5.98
Revenue/Employee
$1,114,286
Employees
56
Market Cap
$373.40M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
62.40M16.30M+35.36%
Dec 31, 2024
46.10M-11.50M-19.97%
Dec 31, 2023
57.60M35.10M+156.00%
Dec 31, 2022
22.50M-15.74M-41.17%
Dec 31, 2021
38.24M-2.42M-5.95%
Dec 31, 2020
40.66M-41.90M-50.75%
Dec 31, 2019
82.56M54.35M+192.66%
Dec 31, 2018
28.21M14.63M+107.66%
Dec 31, 2017
13.59M――